Works matching IS 00070920 AND DT 2013 AND VI 109 AND IP 10


Results: 31
    1
    2
    3

    First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer.

    Published in:
    British Journal of Cancer, 2013, v. 109, n. 10, p. 2579, doi. 10.1038/bjc.2013.619
    By:
    • Bianchini, D;
    • Omlin, A;
    • Pezaro, C;
    • Lorente, D;
    • Ferraldeschi, R;
    • Mukherji, D;
    • Crespo, M;
    • Figueiredo, I;
    • Miranda, S;
    • Riisnaes, R;
    • Zivi, A;
    • Buchbinder, A;
    • Rathkopf, D E;
    • Attard, G;
    • Scher, H I;
    • de Bono, J;
    • Danila, D C
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    DICER1 hotspot mutations in non-epithelial gonadal tumours.

    Published in:
    British Journal of Cancer, 2013, v. 109, n. 10, p. 2744, doi. 10.1038/bjc.2013.637
    By:
    • Witkowski, L;
    • Mattina, J;
    • Schönberger, S;
    • Murray, M J;
    • Huntsman, D G;
    • Reis-Filho, J S;
    • McCluggage, W G;
    • Nicholson, J C;
    • Coleman, N;
    • Calaminus, G;
    • Schneider, D T;
    • Arseneau, J;
    • Stewart, C J R;
    • Foulkes, W D
    Publication type:
    Article
    29
    30
    31